//
Treating Multivessel Coronary Artery Disease in ST-Segment Elevation Myocardial Infarction: Why, How, and When?
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
Cardiac Shock Care Centers: JACC Review Topic of the Week
Canadian SCAD Cohort Study: Shedding Light on SCAD From a United Front
Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock
Utility and Challenges of an Early Invasive Strategy in Patients Resuscitated From Out-of-Hospital Cardiac Arrest
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Advances in Clinical Cardiology 2020: A Summary of Key Clinical Trials